Association of biomarkers and depressive symptoms in schizophrenia

Neuroscience Letters

Volumn 505, Issue 3, 2011, Pages 282-285

  Noto, Cristiano Souza ^a   Gadelha, Ary ^a   Belangero, Síntia Iole ^a   Smith, Marília Arruda Cardoso ^a   de Aguiar, Bianca W ^b   Panizzuti, Bruna ^b,c   Mari, Jair de Jesus ^a   Gama, Clarissa Severino ^b,c   Bressan, Rodrigo Affonseca ^a   Brietzke, Elisa ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Biomarkers; Brain derived neurotrophic factor; Cytokines; Depressive symptoms; Schizophrenia

Indexed keywords

BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CALGARY DEPRESSION SCALE FOR SCHIZOPHRENIA; CLINICAL ARTICLE; CORRELATION ANALYSIS; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; FEMALE; HUMAN; MALE; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSYCHOLOGIC TEST; SCHIZOAFFECTIVE PSYCHOSIS; STRUCTURED INTERVIEW;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CYTOKINES; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; YOUNG ADULT;

EID: 83555165920     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.10.042     Document Type: Article

References (35)

1. Angelucci F., Aloe L., Vasquez P.J., Mathe A.A. Eletroconvulsive stimuli alter nerve growth factor but not brain-derived neurotrophic factor concentrations in brains of a rat model of depression. Neuropeptides 2003, 37:51-56.
2. Angelucci F., Mathe A.A., Aloe L. Neurotrophic factors and CNS disorders: finding in rodent models of depression and schizophrenia. Prog. Brain Res. 2004, 146:151-165.
3. Bleuler E. Dementia praecox or the group of schizophrenias. Monograph Series on Schizophrenia 1950, vol. 1. International University Press, New York.
4. Bressan R.A. Depressão na esquizofrenia. Rev. Bras. Psiquiatr. 2000, 22:27-30.
5. Bressan R.A., Chaves A.C., Shirakawa I., Mari J.J. Validity study of the Brazilian version of the calgary depression scale for schizophrenia. Schizophr. Res. 1998, 32:41-49.
6. Bressan R.A., Costa D.A., Jones H.M., Ell P.J., Pilowsky L.S. Typical antipsychotic drugs-D2 receptor occupancy and depressive symptoms in schizophrenia. Schizophr. Res. 2002, 56:31-36.
7. Brietzke E., Kapczinski F. TNF-alpha as a molecular target in bipolar disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32(August (6)):1355-1361.
8. Buckey P.F., Pillai A., Howell K.R. Brain-derived neurotrophic factor: findings in schizophrenia. Curr. Opin. Psychiatry 2011, 24:122-127.
9. Francesconi L.P., Ceresér K.M., Mascarenhas R., Stertz L., Gama C.S., Belmonte-de-Abreu P. Increased annexin-V and decreased TNF-alpha serum levels in chronic-medicated patients with schizophrenia. Neurosci. Lett. 2011, [Epub ahead of print; June 29].
10. Frommberger U.H., Bauer J., Haselbauer P., Fräulin A., Riemann D., Berger M. Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. Eur. Arch. Psychiatry Clin. Neurosci. 1997, 247:228-233.
11. Gama C.S., Salvador M., Andreazza A.C., Kapczinski F., Silva Belmonte-de-Abreu P. Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia: a study of patients treated with haloperidol or clozapine. Prog. Neuropsychopharmacol. Biol. Psychiatry 2006, 30(May (3)):512-515.
12. Gama C.S., Andreazza A.C., Kunz M., Berk M., Belmonte-de-Abreu P.S., Kapczinski F. Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder. Neurosci. Lett. 2007, 420(June (1)):45-48.
13. Gama C.S., Berk M., Andreazza A.C., Kapczinski F., Belmonte-de-Abreu P. Serum levels of brain-derived neurotrophic factor and thiobarbituric acid reactive substances in chronically medicated schizophrenic patients: a positive correlation. Rev. Bras. Psiquiatr. 2008, 30(December (4)):337-340.
14. Gama C.S., Salvador M., Andreazza A.C., Lobato M.I., Berk M., Kapczinski F., Belmonte-de-Abreu P.S. Elevated serum thiobarbituric acid reactive substances in clinically symptomatic schizophrenic males. Neurosci. Lett. 2008, 433(March (3)):270-273.
15. Gervasoni N., Aubry J.M., Bondolfi G., Osiek C., Schwald M., Bertschy G., Karege F. Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode. Neuropsychobiology 2005, 51(4):234-238.
16. Green M.J., Matheson S.L., Shepherd A., Weickert C.S., Carr V.J. Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis. Mol. Psychiatry 2010, [Epub ahead of print; August 24].
17. Harrow M., Yonan C.A., Sands J.R., Marengo J. Depression in schizophrenia, are neuroleptics, akinesia or anhedonia involved?. Schizophr. Bull. 1994, 20:327-338.
18. Hashimoto K., Shimizu E., Iyo M. Critical role of brain-derived neurotrophic factor in mood disorders. Brain Res. Rev. 2004, 45:104-114.
19. Hashimoto T., Bergen S.E., Nguyen Q.L., Xu B., Monteggia L.M., Pierri J.N., Sun Z., Sampson A.R., Lewis D.A. Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia. J. Neurosci. 2005, 25:372-383.
20. Kraepelin E. Dementia praecox and paraphrenia. Textbook of Psychiatry 1919, E & S Livingstone, Edinburgh, pp. 74-75. German 8th edition.
21. Kunz M., Gama C.S., Andreazza A.C., Salvador M., Ceresér K.M., Gomes F.A., Belmonte-de-Abreu P.S., Berk M., Kapczinski F. Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32(October (7)):1677-1681.
22. Kunz M., Ceresér K.M., Goi P.D., Fries G.R., Teixeira A.L., Fernandes B.S., Belmonte-de-Abreu P.S., Kauer-Sant'anna M., Kapczinski F., Gama C.S. Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance. Rev. Bras. Psiquiatr. 2011, [Epub ahead of print; March 18].
23. Meredith G.E., Callen S., Scheuer D.A. Brain-derived neurotrophic factor expression in increased in the rat amygdale, piriform cortex and hypothalamus following repeated amphetamine administration. Brain Res. 2002, 949:218-227.
24. Miller B.J., Buckley P., Seabolt W., Mellor A., Kirkpatrick B. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol. Psychiatry 2011, [Epub ahead of print; June 3].
25. Nakata K., Ujike H., Sakai A., Uchida N., Nomura A., Imamura T., Katsu T., Tanaka Y., Hamamura T., Kuroda S. Association study of the brain-derived neurotrophic factor (BDNF) gene with bipolar disorder. Neurosci. Lett. 2003, 337:17-20.
26. Pae C.U., Yoon C.H., Kim T.S., Kim J.J., Park S.H., Lee C.U. Antipsychotic treatment may alter T-helper (TH) 2 armcytokines. Int. Immunopharmacol. 2006, 6:666-671.
27. Pedrini M., Chendo I., Grande I., Lobato M.I., Belmonte-de-Abreu P.S., Lersch C., Walz J., Kauer-Sant'anna M., Kapczinski F., Gama C.S. Serum brain-derived neurotrophic factor and clozapine daily dose in patients with schizophrenia: a positive correlation. Neurosci. Lett. 2011, 491(March (3)):207-210.
28. Roy A. Relationship between depression and suicidal behavior in schizophrenia. Depression in Schizophrenia 1990, American Psychiatric Press, Washington (DC). L.E. DeLisi (Ed.).
29. Siris S.G. Depression in schizophrenia: perspective in the Era of "atypical" antipsychotic agents. Am. J. Psychiatry 2000, 157:1379-1389.
30. Smith R.S., Maes M. The macrophage-T-lymphocyte theory of schizophrenia: additional evidence. Med. Hypotheses 1995, 45:135-141.
31. Vargas H.E., Gama C.S., Andreazza A.C., Medeiros D., Stertz L., Fries G., Palha J., Cereser K.M., Berk M., Kapczinski F., Belmonte-de-Abreu P.S. Decreased serum neurotrophin 3 in chronically medicated schizophrenic males. Neurosci. Lett. 2008, 440(August (3)):197-201.
32. Vessoni A.L. Adaptação e estudo de confiabilidade da escala de avaliação das síndromes positiva e negativa para a esquizofrenia no Brasil 1993, Escola Paulista de Medicina, São Paulo.
33. Weickert C.S., Hyde T.M., Lipska B.K., Herman M.M., Weinberger D.R., Kleinma J.E. Reduced brain derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol. Psychiatry 2003, 8:592-610.
34. White L., Harvey P.D., Opler L., Lindenmayer J.P., PANSS Study Group Empirical assessment of the clinical symptoms in schizophrenia. Psychopathology 1997, 30:263-274.
35. Zisook S., Nyer M., Kasckow J., Golshan S., Lehman D., Montross L. Depressive symptom patterns in patients with chronic schizophrenia and subsyndromal depression. Schizophr. Res. 2006, 86:226-233.